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Dietary regimens that favour reduced calorie intake delay aging and age-associated diseases.New evidences revealed that nutritional
balance of dietary components without food restriction increases lifespan. Particular nutrients as several nitrogen sources, proteins,
amino acid, and ammonium are implicated in life and healthspan regulation in different model organisms from yeast to mammals.
Aging and dietary restriction interact through partially overlapping mechanisms in the activation of the conserved nutrient-
signalling pathways, mainly the insulin/insulin-like growth factor (IIS) and the Target Of Rapamycin (TOR).The specific nutrients
of dietary regimens, their balance, and how they interact with different genes and pathways are currently being uncovered. Taking
into account that dietary regimes can largely influence overall human health and changes in risk factors such as cholesterol level
and blood pressure, these new findings are of great importance to fully comprehend the interplay between diet and humans health.
1. Introduction
The primary molecular mechanisms underlying aging have
attracted increased attention, as healthy aging becomes one of
the main concerns of the modern society. Cellular activities
such as the regulation of metabolism, growth, and aging
are modulated by a network of nutrient and energy sens-
ing signalling pathways that are highly conserved among
organisms, from yeasts to mammals (reviewed in [1]). Three
major signalling pathways involved in longevity regulation
have been described: the insulin/insulin-like growth factor
(IIS), the Target Of Rapamycin TOR/Sch9 (ortholog of the
mammalian S6 kinase), and adenylate cyclase/protein kinase
A (AC/PKA). Reducing activity of these pathways is known to
promote health and lifespan extension [1]. Signalling through
IIS/TOR pathways starts with the binding of ligands, such
as insulin and insulin-like growth factor (IGF-1 and IGF-2)
in the case of mammals, to specific receptors, which in turn
activate the PI3K/Akt/mTOR intracellular signalling cascade
that regulates metabolism and stress resistance and conse-
quently aging [2]. Akt kinase directly inhibits the antiaging
forkhead FoxO family transcription factor (FOXO), known
to regulate autophagy, DNA repair, ubiquitin-proteasome
system, and other stress resistance genes [3]. Besides being
activated by insulin and IGF-1 via Akt, highly conserved
TOR can also respond to dietary amino acids while signalling
through other pathways such as the energy sensing pathway
AMP-activated protein kinase (AMPK) and sirtuin pathway
(SIRT1), downregulating rapamycin-sensitive TOR complex
1 (TORC1) activity. AMPK and SIRT1 are known to mediate
longevity in several model organisms in response to dietary
regimens [4]. Detailed description of these nutrient signal-
izing pathways in different models can be found in recently
published reviews [5–9].
The study of aging regulating mechanisms can be accom-
plished by genetic manipulations of these well conserved
nutrient-signalling pathways or by using dietary restriction
(DR) protocols, in which the intake of one or more macronu-
trients is reduced without causing malnutrition. One of the
best documented DR protocols involves reduction of caloric
intake without lack of essential nutrients, termed calorie
restriction (CR). The benefits of CR were first described in
1935, by showing that reduced food intake extended lifespan
of rats [10]. Since then many studies have demonstrated the
beneficial effects of CR on lifespan extension of multiple
organisms (yeast, flies, worms, fish, rodents, and rhesus
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monkeys), as well as on the improvement of overall health
in rodent models. However, new evidences have recently
emerged from studies in yeast [11, 12] and in higher eukary-
otes [13–15] showing the importance of nutrient balance
in dietary regimens and its effects on longevity regulation,
challenging the notion that the indiscriminate reduction of
caloric intake per se extends lifespan. These studies increas-
ingly suggest that not only caloric restriction but rather a bal-
ance of different nutrients and their ratios have a pivotal role
in regulating lifespan [13, 14, 16–18].
In the following sections we start with an overview of dif-
ferent eukaryotic model organisms that allowed establishing
the role of metabolic and growth pathways in longevity. The
subsequent sections highlight the impact of nutrient balance
on the beneficial effects of dietary restriction regimes on
longevity regulation and age-related pathologies.
2. Aging and Dietary Regimens in Different
Eukaryotic Model Organisms
Studies in different eukaryoticmodel organisms revealed that
the pathways regulating metabolism and growth, once active,
are also able to modulate aging and increase mortality.
The yeast Saccharomyces cerevisiae has been a highly
exploited eukaryotic model to study the mechanisms
involved in longevity regulation through the assessment
of cell survival in stationary phase cultures (known as
chronological lifespan—CLS) [19–23]. These studies carried
under different nutrient dietary regimens show that reducing
glucose concentration in the media (usually from 2% to 0.5
or 0.05%) increase CLS [20, 23–28]. Furthermore, several
other single nutrients from the culture medium were also
shown to affect longevity regulation (reviewed in [29]). As in
higher eukaryotes, in S. cerevisiae these nutrients, depending
on their abundance, can activate multiple proaging signalling
pathways, such as the TOR1-Sch9, primarily activated by
amino acids, and the Ras/PKA which mainly responds to
glucose but is also regulated by othermajor nutrients [30–32].
These pathways promote cell division and growth in response
to nutrients while inhibiting the general stress response and
autophagy [26, 33]. CR further promotes CLS extension in
TOR and Sch9p deficient mutants, indicating the presence of
other mechanisms in CR-mediated lifespan extension [26].
The Ras/PKA pathway is the primary mediator of the glucose
transcriptional response [34] and deletion of RAS2 causes
lifespan extension and stress resistance [35], while imposing
CR to long-lived cdc25-10 mutants (deficient in guanine
nucleotide exchange factor that regulates Ras2p activation)
does not further extend lifespan of these mutants [36]. Both
pathways converge on the stress resistance kinase Rim15p and
its downstream transcription factorsMsn2p/4p andGis1p, all
of which play key roles in mediating CR effects on longevity
[26, 37]. Decreasing TOR-Sch9 signalling also extends CLS
in Rim15p independent manner through the modulation
of mitochondrial functions. Actually, it has been shown
that, in active stages of growth, genetic or pharmacological
TOR inhibition results in enhanced mitochondrial coupling,
increasing mitochondrial membrane potential and reactive
oxygen species (ROS) production that provides an adaptive
mitochondrial signal to extend CLS in stationary phase
[38, 39]. Others have also reported that CR extends CLS by
reducing superoxide anion levels, independently of Rim15p,
promoting a more frequent growth arrest in G
0
/G
1
phase
[40, 41]. It has also been shown thatmitochondrial respiratory
thresholds regulate yeast CLS and its extension by CR, a
critical minimum respiratory capacity being crucial for such
CLS extension [42].
The role of IIS in agingmodulation was first discovered in
the nematode Caenorhabditis elegans by demonstrating that
the phosphatidylinositol 3-kinase (PI3K) signalling cascade is
responsible for longevity regulation [43]. Since then, the IIS
pathway has been implicated in other biological functions of
C. elegans [44]. Inhibition of this pathway by using function
mutations in DAF-2, the only C. elegans gene coding for an
insulin/IGF-1 receptor ortholog, reduces the aging process
[45] and leads to transcription changes of stress response and
energymetabolism genes via DAF-16 (FOXOortholog) [1, 45,
46]. As in yeast, downregulation of the TOR-S6K signalling
pathway in C. elegans affects longevity by activating stress
transcription factors, PHA-4, SKN-1, and DAF-16, which
control genes involved in lipid metabolism and autophagy
[47, 48]. Also in this model, the IIS and the TOR pathways
act in synergy through partially overlapping mechanisms to
control longevity [48, 49]. In C. elegans the most common
dietary restriction protocol to reduce the intake of nutrients,
without causing malnutrition (DR), is through the decrease
of the bacterial food source, mainly Escherichia coli, either
by using bacterial dilution, which can extend lifespan from
60% up to 150% [50], or by reducing feeding capability.
Increased lifespan is observed in mutants affected in feeding
capabilities such as deletion of EAT-2 (pharyngeal pumping
defect) as well as decreased activity of NAC-2 and NAC-
3 (gut sodium dicarboxylate transporter) [16, 51, 52]. The
study of the role of specific constituents of diet in longevity
are still lacking due to the absence of purified diets in C.
elegans. However, it is known that high glucose diets shorten
lifespan in this model by downregulating proteins such as
AMPK, FOXO, and glyoxalase [53, 54]. Recently, a glucose
transporter that links nutrient restriction and signalling to
aging, in this simple organism, has also been discovered. The
FGT-1 glucose transporter, a mammalian GLUT-like protein
paralog, seems to be responsible not only for transport
activity but also for glucose signallingmetabolismas reducing
its activity increases lifespan to the same level obtained by
decreasing DAF-2 signalling [53, 55].
In the fruit fly Drosophila melanogaster, reducing IIS
signalling by mutations in the insulin-like peptides (DILPS)
or insulin-like receptor (INR) shows increased lifespan exten-
sion, establishing the role of this pathway as being evolution-
ary conserved [56]. Direct inhibition of TOR pathway in flies
presents a 30% increase in lifespan [57, 58]. However,mutants
in the insulin receptor substrate CHICO still respond to
DR as do null dFOXO mutants, suggesting only partially
overlapping mechanisms for IIS and DR mediated lifespan
extension, indicating the existence of other nutrient respond-
ing pathways [59, 60]. The usual DR protocol in flies is an
ad libitum diluted diet, in which the sugar and yeast content
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Figure 1: Scheme of longevity regulatory pathways in various model organisms (yeast, worms, flies, and mammals). Identical symbols
are used for the orthologous genes in each model organism. In worms, flies, and mammals, dietary restriction reduces signalling through
IIS/TOR pathways, deactivating the PI3K/Akt/TOR intracellular signalling cascade and consequently activating the antiaging FOXO family
transcription factor(s), known to regulate stress resistance and aging. In yeast, dietary restriction reduces the activity of the TOR/Sch9
and RAS/PKA nutrient-signalling pathways, both converging on the protein kinase Rim15 that in consequence activates its downstream
transcription factors Gis1 andMsn2/4, involved in the postdiauxic shift (PDS) element-driven gene expression and stress-responsive elements
(STRE) gene expression, respectively. The involvement of RAS signalling in longevity regulation is indicated in the two models where it has
been described. lysine (Lys.), methionine (Met.), threonine (Thr.), and valine (Val.). The detailed description and other abbreviations are
given in the text.
can be changed to achieve maximal longevity. In fact, using
fixed concentrations of sugar but reducing calories from
yeast (protein source) can significantly extend longevitywhile
restriction of dietary sugar yields only modest extension,
indicating that protein restriction is more important in
lifespan extension in fruit flies [60–62].
As for the othermodels described above, inmammals, the
modulation of the conserved nutrient activated pathways IIS
and mTOR, genetically, pharmacologically, or nutritionally,
impacts aging and delays age-related diseases. Genetic inter-
ventions that limit signalling through IIS pathway in rodents,
such as Ames and Snell dwarfs and growth hormone (GH)
receptor knockout, are capable of extending lifespan in 50%
by diminishing IGF-1 and insulin levels and simultaneously
enhance healthspan (reviewed in [5]). Recently, the beneficial
effects of CR and IGF-1 levels in longevity are proposed to
act through PI3K/Akt/mTOR signalling to reduce mTOR
activity, significantly increasing lifespan [2]. The most com-
mon DR protocol in mammals is the decrease of calorie
intake (CR) which is the most robust dietary intervention to
extend lifespan and healthspan in mammals to date. Other
DR protocols include protein restriction and intermittent
fasting, which do not require a reduction in calorie intake.
CR animals have their caloric diet reduced normally 20 to
40% from the ad libitum diet given to the control animal and
present extended lifespan up to 40% partially by reducing the
occurrence of chronic diseases such as cancer, diabetes, and
cardiovascular diseases. GH stimulates IGF-1 production,
which can be arrested by CR, suggesting that CR uses
longevity pathways to limit cancer probably due to energy
restriction that alters cell cycle regulation and consequently
inhibits cell proliferation and increases apoptosis [63]. CR
has also been reported to reduce oxidative damage to DNA,
by enhancing the efficiency of DNA repair mechanisms
[16, 63]. A schematic illustration of the nutrient-signalling
pathways involved in longevity regulation in the different
model organisms is provided in Figure 1.
3. Nitrogen Sources as Key Effectors on
Dietary Regimens
The results in yeast [11, 64] and in higher eukaryotes,
described above, clearly favour an emerging perspective
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where nutrient balance plays a predominant role in the
beneficial effects of dietary restriction regimens impacting
longevity regulation. Therefore recently several studies tried
to clarify which nutrients are affecting longevity regulation
andwhether they interact. Protein and amino acids have been
studied as activators of specific nutrient signalling pathways
involved in longevity regulation inmultiplemodel organisms.
In the yeast S. cerevisiae, dietary amino acid composition
has been implicated in CLS regulation. Several studies in the
literature report different effects of amino acids on lifespan
regulation, dependent on the TOR pathway [19, 21–23, 65].
In this context, it is known that starvation for nonessential
amino acids used as preferred nitrogen sources can extend
CLS [24, 36, 66], while starvation for essential amino acids
reduces CLS [21, 65]. Single amino acids are known to affect
longevity and, recently, it has been shown that leucine influ-
ences autophagy and extension of CLS during CR [67]. On
the other hand, methionine restriction has been described to
extend CLS in an autophagy-dependent manner [68] and to
confer resistance to multiple cellular stresses through stress-
responsive retrograde signalling [69]. Isoleucine, threonine,
and valine extend CLS via the general amino acid control
(GAAC) pathway [19]. The sensing of certain amino acids,
such as leucine, occurs via TOR kinase while the absence
of individual amino acids is recognized via GCN2 (general
amino acid control nonderepressible 2) [70, 71]. Regulation
of these two kinases has been highly implicated in longevity
modulation by dietary restriction [72]. Besides amino acids,
another nitrogen source commonly used by S. cerevisiae such
as ammonium (NH4
+) was identified as new key player in the
modulation of yeast longevity [73, 74].These studies reported
that NH4
+ is toxic acting as an extrinsic factor affecting yeast
CLS, preferentially in amino acid restriction conditions [73].
In extreme CR conditions in water, NH4
+ effects during yeast
aging depend on the specific essential amino acid deprived
from themedium, with leucine or histidine deprivation being
mediated by Tor1p activation and lysine deprivation by Ras2p
activation. Sch9p, contrary to Tor1p and Ras2p, mediates
cell survival in response to NH4
+ associated with Sch9p-
dependentHog1p phosphorylation [74].These results suggest
that the presence of NH4
+ in themedium (commonly present
as the nitrogen source) may be at least partly responsible for
the reported decrease in CLS in leucine-starved cells [19, 67].
This work provided new insights into the modulation of CLS
by several nutrients, linking NH4
+ toxicity to amino acid
limitation [74].
In C. elegans, amino acids and proteins are influencing its
lifespan through DR. In this scope, it has been shown in a
recent study that GCN2, the evolutionarily conserved kinase
that directly responds to amino acid deficiency, plays a central
role in mediating lifespan extension under DR conditions
by converging with TOR/S6K signalling on the PHA-4/FoxA
transcription factors and its downstream target genes under
stressful conditions [75, 76]. Reducing the uptake of pep-
tides, by Pep-2 deletion, also increases lifespan by reducing
insulin signalling [77] and, additionally, mutations in Metr-
1/methionine synthase or the use of the common antidiabetic
drug metformin, which alters methionine metabolism, is
also known to extend lifespan in C. elegans [78]. The roles
of specific components of the diet in longevity regulation
versus reduced calorie intake in C. elegans are still difficult
to elucidate due to the deficiency of purified diets and lack
of studies connecting each nutrient contribution and the
various pathways implicated in aging.
In Drosophila melanogaster, a recent study demonstrated
that adding back essential amino acids to DR flies increased
fecundity and decreased lifespan back to the full feeding
level, while adding back other yeast nutrients, as fatty acids,
vitamins, or carbohydrates, add no effect on lifespan nor on
fecundity [13]. These results demonstrate that the amount of
calories per se does not affect lifespan. However, supplement-
ing with methionine by itself increased fecundity to the fully
fed level, without reducing lifespan, demonstrating that the
assumed tight link between lifespan and fecundity could be
uncoupled. Other studies support thatmethionine and casein
supplementation led to extended longevity. On the contrary,
a recent study reported positive effects of methionine restric-
tion on longevity in a defined diet, only in the presence
of relatively low total amino acids, by downregulating TOR
signalling [79]. In order to clarify these different responses to
amino acids and in particular to methionine which suggests
a possible cross talk between the response pathways of the
various amino acids, the use of a fully defined diet such as the
complete chemically defined (holidic) diet available for D.
melanogaster developed by Piper and coworkers [80] has
been recommended. The use of this diet has confirmed the
positive effects of amino acid dietary restriction on lifespan
regulation as well as the negative effect of complete lack of
methionine on lifespan extension [61, 80]. This holidic diet is
now a promising tool to study the role of individual nutrients
in longevity regulation in flies.
As referred above, besides CR, other DR protocols are
used successfully in mammal studies on longevity. Recent
reports demonstrate that rodents on low protein regimens
with 5–15% protein live longer than the ones on high-
protein diets with 50% protein intake [14]. This extended
longevity due to the fact that protein restriction is associated
with reduced mTOR activation, reduced DNA and protein
oxidative damage, and reduced spontaneous tumor forma-
tion and has been demonstrated to improve renal function
[81]. Restriction of single amino acids like methionine and
tryptophan has also been described to have a role in longevity
regulation in mammals. Studies show that rodents given 80%
reduced methionine diet displayed an increase in median
and maximum lifespan of 40% in comparison to the con-
trolled fed animals. Methionine restricted rodents exhibit
reduced levels of insulin, IGF-1, serum glucose, and mito-
chondrial ROS, similar to CR restricted animals, although
by partially independent pathways [82, 83]. Also, tryptophan
restriction has been described to extend mice lifespan by
23% [16] accompanied with delayed sexual maturation and
tumor onset and improved hair growth and coat condi-
tion. Leucine restriction also appears to be implicated in
longevity extension probably by increasing insulin sensitivity
via GCN2/mTOR and AMPK pathways [81]. Accordingly,
the amino acid sensing pathways GCN2 and mTOR and
their cross talk can most probably be implicated in longevity
regulation in protein restriction regimens [84].
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4. Dietary Restriction versus Dietary Balance
As described above, traditional DR differs even within
experiments using the same model organism. DR can be
implemented by using a diet of constant composition or
diets in which the composition varies, either by providing
limited food intake or by using a diluted diet. Due to these
major discrepancies in DR protocols amongst the major
aging models, recent studies have been using the Geometric
Framework (GF) approach, consisting of a multidimensional
representation of nutrition, in order to better understand the
effects of dietary nutrients on feeding behaviour, metabolic
health, reproduction, and longevity, among other traits [85].
From these studies emerged the concept that macronutrient
ratios between protein and carbohydrates (P : C ratio), but
not fat, have key roles in longevity regulation in these models
[13, 14, 18, 62]. In fruit flies increased longevity was achieved
by reducing the caloric input from the protein source yeast
extract. This DR-regimen ameliorated lifespan extension in
comparison to isocaloric reduction of sucrose [62]. Similarly,
addition of essential amino acids to dietary restriction in
sucrose plus yeast-based diet diminishes longevity extension
[13]. Another study demonstrated that 1P : 16C diet ratio
maximized D. melanogaster lifespan, while reduced caloric
intake did not extend lifespan [18]. In rodents, increasing
the P : C ratio affects longevity without being influenced by
total calorie intake, ultimately leading to an increased mTOR
activation. The longest lifespan extension was achieved by a
low protein high carbohydrate diet, which the authors believe
to result from low mTOR activation and low insulin levels.
Inhibition of mTOR, a proaging pathway, by manipulating
the ratio of macronutrients is believed to extend longevity in
rodents [14]. As described above, mTOR and IGF-1 signalling
by amino acids and the effect of low protein diets on longevity
regulation suggest further investigation into how dietary
balance affects aging.
Also in primates, DR composition has a major impact in
results regarding lifespan extension, supporting the notion
that balance of nutrients in the diet might be more important
in healthy lifespan extension than dietary restriction. Two
studies, one from the Wisconsin National Primate Research
Centre (WNPRC) and another from the National Institute
on Aging (NIA) presented different results when subjecting
rhesus monkeys to 30% CR regimen. The WNPRC study
reported a decreased mortality in the CR group in com-
parison to the control group with a 50% lower incidence
of diabetes, cancer, and cardiovascular diseases [17, 86].
On the other hand, the NIA study did not find significant
differences between CR and control groups, although sup-
porting the beneficial impact of CR on healthspan [87].
The major differences between these two studies were the
dietary regimens and the protein and carbohydrate sources
used in each study. In the WNPRC study, the protein source
used was lactalbumin and the carbohydrate source derived
from corn, starch, and 28.5% sucrose, whereas, in the NIA
study, the protein source used derived from wheat, corn,
soybean, fish, and alfalfa meal, and the carbohydrate source
derived from ground wheat and corn with 3.9% sucrose [81].
The differences in results from the two studies could be
attributed to the variations in food ingredients and possibly
to the protein source; one derived from animal and the
other derived from plant sources that have been previously
described to affect aging [81, 88].
In humans, very recent cohort studies suggest a corre-
lation between age-related diseases and high protein diets
from animal sources. Based on the US national survey of
health and nutrition, NHANES III database, a recent article
reports that the 50-to-65 age group with high protein intake
had a 75% increase in overall mortality and a fourfold
increased risk of cancer mortality in comparison to individu-
als with lowprotein intake, whichwas attenuated or abolished
when protein intake was derived from plants. Interestingly,
in individuals over 65 years, the high protein intake was
reported to reduce cancer and overall mortality.These results
were confirmed in mice, proving that protein absorption is
affected by aging. The study also confirms the correlation
between higher IGF-1 levels with more dietary protein and
the incidence and progression of both melanoma and breast
cancer [15]. Likewise, a Swedish cohort reported that low
carbohydrate high protein diets are associated with increased
risk of cardiovascular diseases [89].
Although the yeast aging model has been pioneer in
uncovering many age-related processes, only recently studies
addressing dietary balance started to emerge. A recent study
shows a nutritional balance occurring between glucose,
amino acids, and yeast nitrogen base (YNB) as having a
major role in yeast CLS through Sch9p [11]. The same
authors have also shown that the ratio between essential and
nonessential amino acids greatly affects CLS regulation, in
a glucose dependent manner, as a significantly shorter CLS
was observed under CR conditions. Methionine restriction
and glutamic acid addition were also reported to maximize
CLS, and a positive correlation between the additive effects
of methionine restriction and glutamic acid addition with
CR in CLS was also reported [90]. These reports suggest
that also in yeast the well-known CR effect in longevity
is strongly dependent on other nutrients in the medium
compared to glucose alone. Also, a recent study uncovered
how glucose and amino acids (threonine, valine, and serine)
modulate stress and aging in yeast [64]. In this study it
was reported that, in the presence of glucose, threonine
and valine activated TORC1 pathway and serine activated
the sphingolipid dependent Pkh1/2 pathway. Both activated
pathways converged to active Sch9p which plays a critical
role in this nutrient response mechanism. Sch9p seems to
be directly involved in nutritional balance in yeast as a new
study reports antagonistic effects of SCH9 deletion on yeast
cells grown in synthetic complete medium and natural grape
juice, where the nitrogen : carbon ratio significantly differs
[91]. In line with these latest results, the CLS shortening
under amino acid restriction can be completely reverted
by removing nonlimiting good nitrogen sources (NH4
+ or
glutamine) from the medium and furthermore NH4
+ is a
necessary nutrient for the beneficial effects of CRon longevity
to occur [12]. The presence of ammonium is responsible for
inducing replicative stress and blocking the consumption
of essential amino acids. Furthermore, the negative effects
of NH4
+ are mediated by Tor1p, Ras2p, and Sch9p. These
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results further establish NH4
+ as a key factor involved in
the nutritional balance required between nitrogen sources
and glucose, to achieve longevity promotion in yeast [12]. A
schematic illustration of dietary balance in yeast is provided
in Figure 2. These new reports demonstrating that extended
lifespan as well as healthspan does not depend only on calorie
or dietary restriction but rather on an optimal nutritional
equilibriummay have significant acceptance from the general
population and a broader application than dietary restriction
in worldwide diet regimens [13, 14, 16–18].
5. The Interplay between Diet and
Age-Related Pathologies
Dietary restriction, as mentioned above, is a potent inter-
vention that increases lifespan and contributes to a lower
incidence of chronic diseases, namely, cancer [17, 63]. How-
ever, although DR presents high advantages to the aging
process and associated diseases, long-term food restriction is
unfeasible for most people, therefore presenting low clinical
value [92]. Also, inadequate nutrition is known to reduce
reproductive function and increase the risk of osteoporotic
bone fractures and cardiac arrhythmias [3]. To overcome
this low compliance to food DR, a promising strategy is to
use DR mimetics, by the development of pharmaceutical
compounds that lead to the same physiological effects as DR
without significantly reducing food intake. The best studied
DR mimetics are rapamycin, metformin, and resveratrol,
which have shown anticancer properties and consequently
are being tested in clinical trials [63]. Several studies report
the effects of metformin, a well-known antidiabetic drug,
on reducing spontaneous tumor growth and also increasing
the efficacy of radiation in cancer treatment [93, 94]. These
beneficial effects of metformin are primarily mediated by
the activation of AMPK pathway, known to regulate cellular
energy homeostasis, but also by signaling suppression of
mTORC1 [63, 93]. The TORC1 inhibitor rapamycin or its
analogs induces cell death in breast and colorectal cancer
subjected to therapeutic drugs, leading to tumor regression
[63]. Resveratrol has been used as CR mimetic known to
activate SIRT1 andAMPKwith beneficial effects on longevity,
cancer, and obesity [95]. The new field of DR mimetics
brings to light the vast applications in cancer metabolism and
these novel results associating DRmimetics to chemotherapy
agents can help reduce the side effects of treated cells by
protecting normal cells from stress induced death [63].
Fasting is a dietary regimen that has proven to trigger
similar biological pathways as caloric restriction and has
gained popularity over the years with people finding it
easier to follow than traditional DR. Intermittent fasting (IF)
involves restriction of energy intake for periods of 1-2 days
a week with no restriction during feeding periods whereas
periodic fasting (PF) involves fasting for 3 ormore days every
2 or more weeks, also with no restriction during feeding
periods. Fasting for a period of 2 or 5 days is known to
promote a 50% reduction in glucose and IGF-1 levels in both
mice and humans, respectively, and to promote depletion
of hepatic glycogen, leading to the generation of ketone
bodies [96]. In cancer treatment, fasting has shown to have
more consistent positive effects than DR. Fasting generates
an extreme environment that induces protective changes in
normal cells, but not in cancer cells, that fail to respond to
the protective signals of fasting due to the role of oncogenes as
negative regulators of stress resistance.This effect is called dif-
ferential stress resistance (DRS) [97]. On the contrary, long-
term DR requires a period of weeks or even months to have
some effect and is not capable of achieving high decreases
in glucose and IGF-1 levels, besides promoting chronic
weight loss, considered detrimental to patients undergoing
chemotherapy [63, 96, 97]. Studies in mice have reported
that combining fasting cycles and chemotherapy increased
cancer-free survival in 20–60% [98, 99] and is effective in
improving chemotherapeutic index [100]. Although there are
no human data so far, the effect of fasting on enhancing can-
cer treatment is being tested in clinical trials in both Europe
and the USA [96]. IF has also shown major health benefits in
both rodents and humans, being able to lower the risk factors
associatedwithmetabolic syndrome (MS), such as abdominal
fat, blood pressure, inflammation, and insulin resistance, and
consequently diminish the risk factor for diabetes and cardio-
vascular diseases [101–104]. IF can reduce inflammation in
rheumatoid arthritis patients and asthma-related symptoms
in overweight subjects, inducing significant decreased levels
in oxidative stress and inflammation markers [105, 106].
Studies linking IF and cognitive brain function in humans
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are still scarce; however, recently, dietary patterns have been
linked to brain biomarkers of Alzheimer’s disease [107]. In
fact, in rodent models of Alzheimer’s, Parkinson’s, and Hunt-
ington’s disease, IF reduced clinical symptoms, protecting
neurons against dysfunction and degeneration by inducing
the expression of brain-derived neurotrophic factor (BDNF)
[108–110], which suggest that IF interventions could also
present benefits in the prevention of brain dysfunction in
humans.
Summing up, evidence reported herewith shows that
multiple dietary regimens can largely influence overall
health and longevity. Nutrient modulating mechanisms are
presently being uncovered in different organisms from yeast
to mammals, exposing the balance between several nutrients
as primordial to aging. These new findings are of great
importance to fully comprehend the interplay between diet
and humans health.
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